149 related articles for article (PubMed ID: 356723)
1. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.
Jackson RT; Harris LF; Alford RH
Antimicrob Agents Chemother; 1978 Jul; 14(1):118-25. PubMed ID: 356723
[TBL] [Abstract][Full Text] [Related]
2. Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.
Jackson RT; Thomas FE; Alford RH
Antimicrob Agents Chemother; 1977 Jan; 11(1):84-7. PubMed ID: 319753
[TBL] [Abstract][Full Text] [Related]
3. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
Lemozy J; Sirot D; Chanal C; Huc C; Labia R; Dabernat H; Sirot J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2580-2. PubMed ID: 8585751
[TBL] [Abstract][Full Text] [Related]
4. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
Papanicolaou GA; Medeiros AA; Jacoby GA
Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
[TBL] [Abstract][Full Text] [Related]
5. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin.
Hoeprich PD; Huston AC
J Infect Dis; 1976 Jun; 133(6):681-5. PubMed ID: 778303
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
Tzouvelekis LS; Tzelepi E; Mentis AF; Tsakris A
J Antimicrob Chemother; 1993 May; 31(5):645-54. PubMed ID: 8335495
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactamase resistance of cephazolin and other cephalosporins.
Goodwin CS; Hill JP
Scott Med J; 1976 Sep; 20(5):236-9. PubMed ID: 772808
[TBL] [Abstract][Full Text] [Related]
8. [Identification of a new penicillinase in a Klebsiella pneumoniae strain of which a mutant also produces an esterase hydrolyzing cephalothin and cefotaxime].
Ben Yaghlane-Bouslama H; Petit A; Sofer L; Sirot J; Boujnah A; Kallel H; Labia R
Pathol Biol (Paris); 1992 Jan; 40(1):31-5. PubMed ID: 1570180
[TBL] [Abstract][Full Text] [Related]
9. SHV Hyperproduction as a Mechanism for Piperacillin-Tazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible
Han MS; Park KS; Jeon JH; Lee JK; Lee JH; Choi EH; Lee SH
Microb Drug Resist; 2020 Apr; 26(4):334-340. PubMed ID: 31651221
[TBL] [Abstract][Full Text] [Related]
10. Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.
Dumon L; Adriaens P; Anné J; Eyssen H
Antimicrob Agents Chemother; 1979 Feb; 15(2):315-7. PubMed ID: 311619
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
Meyer RD
J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
[TBL] [Abstract][Full Text] [Related]
12. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.
Raveh D; Yinnon AM; Broide E; Rudensky B
Chemotherapy; 2007; 53(3):185-9. PubMed ID: 17347564
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases.
Manchanda V; Singh NP; Goyal R; Kumar A; Thukral SS
Indian J Med Res; 2005 Oct; 122(4):330-7. PubMed ID: 16394326
[TBL] [Abstract][Full Text] [Related]
14. Relationship between β-lactamase production and resistance phenotype in Klebsiella pneumoniae strains.
Kim J; Ding T; Ahn J
FEMS Microbiol Lett; 2017 Jul; 364(13):. PubMed ID: 28591808
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
16. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
Paisley JW; Washington JA
Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
[TBL] [Abstract][Full Text] [Related]
18. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW
J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080
[TBL] [Abstract][Full Text] [Related]
19. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
20. Transfer of antibiotic resistance and production of extended-spectrum beta-lactamase (ESBL) in nosocomial Klebsiella pneumoniae strains from two hospitals in Czech Republic.
Blahová J; Králiková K; Krcméry V; Torsová V
Zentralbl Bakteriol; 1997 Nov; 286(4):449-55. PubMed ID: 9440193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
